Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism

Abstract :

Thiazolidinediones (TZDs) represent an interesting treatment of type 2 diabetes mellitus. However, adverse effects such as heart problems and bone fractures have already been reported. Previously, we reported that pioglitazone and rosiglitazone induce osteocyte apoptosis and sclerostin up-regulation; however, the molecular mechanisms leading to such effects are unknown. In this study, we found that TZDs rapidly activated Erk1/2 and p38. These activations were mediated through Ras proteins and GPR40, a receptor expressed on the surface of osteocytes. Activation of this pathway led only to osteocyte apoptosis but not sclerostin up-regulation. On the other hand, TZDs were capable of activating peroxisome proliferator-activated receptor-γ, and activation of this signaling pathway led to sclerostin up-regulation but not osteocyte apoptosis. This study demonstrates two distinct signaling pathways activated in osteocytes in response to TZDs that could participate in the observed increase in fractures in TZD-treated patients.

Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Okina Université d'Angers <>
Soumis le : mercredi 16 juin 2021 - 12:24:22
Dernière modification le : jeudi 17 juin 2021 - 03:43:33


Fichiers produits par l'(les) auteur(s)




Aleksandra Mieczkowska, Michel-Félix Baslé, Daniel Chappard, Guillaume Mabilleau. Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2012, 287 (28), pp.23517 - 23526. ⟨10.1074/jbc.M111.324814⟩. ⟨hal-03262120⟩



Consultations de la notice


Téléchargements de fichiers